SRS Capital Advisors »

Gt Biopharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Gt Biopharma (GTBP) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Gt Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Gt Biopharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gt Biopharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $38k 94k 0.41

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Blackrock Etf Trust Ishares Us Equit (DYNF)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Intermed (INMU)
Spdr Series Trust State Street Spd (TFI)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
NVIDIA Corporation (NVDA)
Blackrock Etf Trust Ishares Us Thema (THRO)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for SRS Capital Advisors

Top funds holding Gt Biopharma

Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
SRS Capital Advisors
Citadel Advisors
SeaCrest Wealth Management
UBS Group
Two Sigma Securities
LPL Financial
Invst
Keel Point
HPM Partners
Integrated Wealth Concepts
Private Wealth Management Group
Coston, McIsaac & Partners

View all funds holding Gt Biopharma